International Guideline Harmonization Group
  • Home
  • About IGHG
    • Members
      • Core group
      • Guideline panels
        • Breast cancer
        • Cardiomyopathy
        • Premature ovarian insufficiency
        • Male gonadotoxicity
        • Thyroid cancer
        • Ototoxicty
        • Obstetric care
        • Central nervous system neoplasms
        • Fatigue, mental health and psychosocial problems
        • Fertility preservation
        • Hypothalamic-pituitary dysfunction
        • Coronary artery disease
        • Metabolic syndrome
        • Pulmonary dysfunction
        • Bone toxicity
        • Hepatic toxicity
        • Nephrotoxicity
        • Neurocognitive problems
        • Colorectal cancer
        • Thyroid dysfunction
        • Splenic dysfunction
    • Collaborators
    • Funding sources
    • Methods
      • Process
      • Grading system
      • Topic selection
      • Publication
      • Handbook
  • Guidelines
    • Topics
      • Breast cancer
        • Recommendations
        • Conclusions of evidence
        • Evidence tables
        • Publication
        • Guideline panel
      • Cardiomyopathy
        • Recommendations
        • Conclusions of evidence
        • Evidence tables
        • Publication
        • Guideline panel
      • Premature ovarian insufficiency
        • Recommendations
        • Conclusions of evidence
        • Evidence tables
        • Publication
        • Guideline panel
      • Male gonadotoxicity
        • Recommendations
        • Conclusions of evidence
        • Evidence tables
        • Publication
        • Guideline panel
      • Thyroid cancer
        • Recommendations
        • Conclusions of evidence
        • Evidence tables
        • Publication
        • Guideline panel
      • Ototoxicity
        • Recommendations
        • Conclusions of evidence
        • Evidence tables
        • Publication
        • Guideline panel
      • Obstetric care
        • Recommendations
        • Conclusions of evidence
        • Evidence tables
        • Publication
        • Guideline panel
      • Central nervous system neoplasms
        • Recommendations
        • Conclusions of evidence
        • Evidence tables
        • Publication
        • Guideline panel
      • Fatigue
        • Recommendations
        • Conclusions of evidence
        • Evidence tables
        • Publication
        • Guideline panel
      • Psychosocial problems
        • Guideline panel
      • Mental health problems
        • Guideline panel
      • Fertility preservation
        • Recommendations
        • Conclusions of evidence
        • Evidence tables
        • Publications
        • Guideline panel
      • Hypothalamic-pituitary dysfunction
        • Guideline panel
      • Coronary artery disease
        • Guideline panel
      • Metabolic syndrome
        • Guideline panel
      • Pulmonary dysfunction
        • Guideline panel
      • Bone toxicity
        • Guideline panel
      • Hepatic toxicity
        • Guideline panel
      • Nephrotoxicity
        • Guideline panel
      • Colorectal cancer
        • Guideline panel
      • Neurocognitive problems
        • Guideline panel
      • Thyroid dysfunction
        • Guideline panel
      • Splenic dysfunction
        • Guideline panel
  • Patient education
  • News
  • Meetings
  • Contact

News

Home News

News archive

  • March 2021
  • October 2020
  • September 2020
  • April 2020
  • February 2019
  • January 2017
  • August 2016
  • July 2016
  • April 2015
  • September 2014
  • October 2013
  • August 04, 2016

    Premature ovarian insufficiency surveillance recommendations published

    The premature ovarian insufficiency surveillance recommendations have been published in the Journal of Clincal Oncology 2016;epub ahead of print.

    Read more
  • July 13, 2016

    Update handbook guideline development

    The update of the Handbook for Guideline Development is now available.

    Read more
  • April 13, 2015

    Cardiomyopathy surveillance recommendations published

    The cardiomyopathy surveillance recommendations have been published in The Lancet Oncology 2015;16:e123-136.

    Read more
123456
  • Contact
  • Disclaimer

© International Guideline Harmonization Group